Regulation of HLA-DR and Costimulatory B7 Molecules in Human Thyroid Carcinoma Cells: Differential Binding of Transcription Factors to the HLA-DRα Promoter

Thyroid ◽  
1998 ◽  
Vol 8 (5) ◽  
pp. 361-369 ◽  
Author(s):  
NITZA LAHAT ◽  
MICHAL A. RAHAT ◽  
ORIT SADEH ◽  
AMALIA KINARTY ◽  
ZAKI KRAIEM
Keyword(s):  
Transcription Factors ◽  
Thyroid Carcinoma ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Hla Dr ◽  
B7 Molecules ◽  
Differential Binding

Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells

2017 ◽  
Vol 150 ◽  
pp. 408-416 ◽  
Author(s):  
Maria Chiara Cristiano ◽  
Donato Cosco ◽  
Christian Celia ◽  
Andra Tudose ◽  
Rosario Mare ◽  
...  
Keyword(s):  
Retinoic Acid ◽  
Thyroid Carcinoma ◽  
Anticancer Activity ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid

Coexpression of Functionally Active Receptors for Thyrotropin and Platelet-Derived Growth Factor in Human Thyroid Carcinoma Cells*

Endocrinology ◽  
1991 ◽  
Vol 129 (4) ◽  
pp. 2187-2193 ◽  
Author(s):  
NILS-ERIK HELDIN ◽  
DUBRAVKA CVEJIĆ ◽  
STAFFAN SMEDS ◽  
BENGT WESTERMARK
Keyword(s):  
Growth Factor ◽  
Thyroid Carcinoma ◽  
Carcinoma Cells ◽  
Platelet Derived Growth Factor ◽  
Human Thyroid

scholarly journals Differential roles of RET isoforms in medullary and papillary thyroid carcinomas

2017 ◽  
Vol 24 (1) ◽  
pp. 53-69 ◽  
Author(s):  
Eric Y Lian ◽  
Sarah M Maritan ◽  
Jessica G Cockburn ◽  
Katayoon Kasaian ◽  
Mathieu J F Crupi ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Cell Survival ◽  
Tumour Progression ◽  
Carcinoma Cells ◽  
Protein Isoforms ◽  
Human Thyroid ◽  
Papillary Thyroid ◽  
Anoikis Resistance ◽  
Thyroid Carcinomas ◽  
And Migration

The RET receptor tyrosine kinase mediates cell proliferation, survival and migration in embryogenesis and is implicated in the transformation and tumour progression in multiple cancers. RET is frequently mutated and constitutively activated in familial and sporadic thyroid carcinomas. As a result of alternative splicing, RET is expressed as two protein isoforms, RET9 and RET51, which differ in their unique C-terminal amino acids. These isoforms have distinct intracellular trafficking and associated signalling complexes, but functional differences are not well defined. We used shRNA-mediated knockdown (KD) of individual RET isoforms or of total RET to evaluate their functional contributions in thyroid carcinoma cells. We showed that RET is required for cell survival in medullary (MTC) but not papillary thyroid carcinoma (PTC) cells. In PTC cells, RET depletion reduced cell migration and induced a flattened epithelial-like morphology. RET KD decreased the expression of mesenchymal markers and matrix metalloproteinases and reduced anoikis resistance and invasive potential. Further, we showed that RET51 depletion had significantly greater effects on each of these processes than RET9 depletion in both MTC and PTC cells. Finally, we showed that expression of RET, particularly RET51, was correlated with malignancy in a panel of human thyroid tumour tissues. Together, our data show that RET expression promotes a more mesenchymal phenotype with reduced cell–cell adhesion and increased invasiveness in PTC cell models, but is more important for tumour cell survival, proliferation and anoikis resistance in MTC models. Our data suggest that the RET51 isoform plays a more prominent role in mediating these processes compared to RET9.

scholarly journals Ligands for Peroxisome Proliferator-Activated Receptor γ Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells

2001 ◽  
Vol 86 (5) ◽  
pp. 2170-2177 ◽  
Author(s):  
Kazuyasu Ohta ◽  
Toyoshi Endo ◽  
Kazutaka Haraguchi ◽  
Jerome M. Hershman ◽  
Toshimasa Onaya
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Cell Lines ◽  
Carcinoma Cell ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Peroxisome Proliferator ◽  
Papillary Thyroid ◽  
Peroxisome Proliferator Activated Receptor ◽  
Carcinoma Cell Lines

Ligands for peroxisome proliferator-activated receptor γ (PPARγ) induce apoptosis and exert antiproliferative effects on several carcinoma cell lines. The present study investigates the expression of PPARγ and the possibility that agonists for PPARγ also inhibit the growth of human thyroid carcinoma cells. We examined this hypothesis using six cell lines, designated BHP thyroid carcinoma cells, which originated from patients with papillary thyroid carcinoma. RT-PCR analysis revealed that the thyroid carcinoma cell lines BHP2–7, 7–13, 10–3, and 18–21 express PPARγ. More PPARγ was expressed in carcinoma than in adjacent normal thyroid tissue in three of six samples of human papillary carcinoma of the thyroid. PPARγ-positive thyroid carcinoma cells were treated with agonists of PPARγ, troglitazone, BRL 49653, and 15-deoxy-Δ12,14-prostaglandin J2. Troglitazone (10μ mol/L), BRL 49653 (10 μmol/L), and 15-deoxy-Δ12,14-prostaglandin J2 (1 μg/mL) decreased[ 3H]thymidine incorporation and reduced cell number, respectively, in BHP carcinoma cell lines that expressed PPARγ. Under low serum conditions, ligands for PPARγ induced condensation of the nucleus and fragmentation of chromatin into nucleosome ladders. These findings indicate that the death of thyroid carcinoma cells is a form of apoptosis. To investigate the molecular mechanism of the apoptosis, we assessed expression of the apoptosis-regulatory genes bcl-2, bax, and c-myc. Troglitazone significantly increased the expression of c-myc messenger RNA but had no effect on the expression of bcl-2 and bax in thyroid carcinoma cells. These results suggest that, at least in part, the induction of apoptosis in human papillary thyroid carcinoma cells may be due to an increase of c-myc. Troglitazone (500 mg/kg·day) significantly inhibited tumor growth and prevented distant metastasis of BHP18–21 tumors in nude mice in vivo. Taken together, these results suggest that PPARγ agonist inhibit cell growth of some types of human thyroid cancer.

scholarly journals The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells

2008 ◽  
Author(s):  
Astrid Kehlen ◽  
Cuong Hoang-Vu ◽  
Jürgen Langner ◽  
Henning Dralle ◽  
Thomas Klonisch ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Cellular Localization ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Biological Functions

Thymosin β-10 Protein Synthesis Suppression Reduces the Growth of Human Thyroid Carcinoma Cells in Semisolid Medium

Thyroid ◽  
2002 ◽  
Vol 12 (9) ◽  
pp. 765-772 ◽  
Author(s):  
Giovanni Santelli ◽  
Paola Cannada Bartoli ◽  
Ada Giuliano ◽  
Antonio Porcellini ◽  
Alba Mineo ◽  
...  
Keyword(s):  
Protein Synthesis ◽  
Thyroid Carcinoma ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Semisolid Medium

scholarly journals IFNγ sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression

Oncogene ◽  
2003 ◽  
Vol 23 (4) ◽  
pp. 928-935 ◽  
Author(s):  
Su He Wang ◽  
Emese Mezosi ◽  
Julie M Wolf ◽  
Zhengyi Cao ◽  
Saho Utsugi ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Carcinoma Cells ◽  
Human Thyroid ◽  
Induced Apoptosis
Sign in / Sign up

Export Citation Format

Share Document